Skip to main content
Premium Trial:

Request an Annual Quote

CORRECTED: Packard and Microarrays

NEW YORK, Jan 17 – A January 8 story about Packard BioScience has been clarified to reflect the company’s decision not to commercialize DNA chips, not microarrays, as previously stated. While the company has decided not to market DNA chips, Packard BioScience still intends to sell its microarray technology and to manufacture and sell protein chips.

The archived version of the story has been altered to more clearly reflect the company’s plans.

GenomeWeb apologizes for any confusion.   

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.